Zentrum für Innere Medizin, Klinik für Kardiologie, Angiologie und Pneumologie, Universitätsklinikum Heidelberg, Germany.
Zentrum für Innere Medizin, Klinik für Kardiologie, Angiologie und Pneumologie, Universitätsklinikum Heidelberg, Germany.
Clin Biochem. 2022 Jan;99:9-16. doi: 10.1016/j.clinbiochem.2021.09.009. Epub 2021 Sep 24.
To evaluate the prognostic value of eleven microRNAs (miRNAs) compared to high-sensitivity Troponin T (hs-cTnT) in patients presenting with suspected acute coronary syndrome (ACS) to the emergency department (ED).
1,042 patients presenting between August 2014 and April 2017 were included. Expression levels of eleven microRNAs (miR-21-5p, miR-22-3p, miR-29a-3p, miR-92a-3p, miR-122-5p, miR-126-3p, miR-132-3p, miR-133a-3p, miR-134-5p, miR-191-3p, and miR-423-5p) were determined using RT-qPCR. All-cause mortality (ACM) and a composite of ACM, acute myocardial infarction (AMI) and stroke were defined as endpoints.
During a median follow-up of 399 (P25-P75: 381-525) days 58 patients (5.6%) died. The composite endpoint occurred in 86 patients (8.3%). Different expression levels of miR-21-5p (median, P25-P75: 5.28 [5.14-5.51] vs. 5.16 [4.97-5.35], p = 0.0033) and miR-122-5p (median, P25-P75: 5.17 [4.81-5.49] vs. 5.35 [5.01-5.69], p = 0.0184) were observed in patients who died compared to survivors. ROC-optimized cutoff of miR-21-5p (HR, P25-P75: 3.3 [1.2-9.4], p = 0.0239), but not miR-122-5p (HR, P25-P75: 0.4 [0.2-0.8], p = 0.0116), was predictive for all-cause mortality, even after adjustment in a multivariate model. Nevertheless, addition of miR-21-5p and miR-122-5p decreased prognostic accuracy of hs-cTnT for all-cause mortality (△AUC: 0.112, p = 0.0159). Hs-cTnT admission values had a high prognostic value for ACM (AUC [95%CI] = 0.794 [0.751-0.837]) and the composite of ACM, AMI and stroke (AUC [95%CI] = 0.745 [0.695-0.794]).
Despite a different expression depending on outcomes miR-21-5p and miR-122-5p do not add prognostic information to hs-cTnT in patients presenting with suspected ACS to the ED.
评估 11 种 microRNAs(miRNAs)与高敏肌钙蛋白 T(hs-cTnT)在急诊科(ED)就诊的疑似急性冠状动脉综合征(ACS)患者中的预后价值。
纳入 2014 年 8 月至 2017 年 4 月期间的 1042 名患者。使用 RT-qPCR 测定 11 种 microRNAs(miR-21-5p、miR-22-3p、miR-29a-3p、miR-92a-3p、miR-122-5p、miR-126-3p、miR-132-3p、miR-133a-3p、miR-134-5p、miR-191-3p 和 miR-423-5p)的表达水平。全因死亡率(ACM)和 ACM、急性心肌梗死(AMI)和中风的复合终点被定义为终点。
在中位随访 399(P25-P75:381-525)天内,58 名患者(5.6%)死亡。86 名患者(8.3%)发生复合终点。miR-21-5p(中位数,P25-P75:5.28[5.14-5.51]vs.5.16[4.97-5.35],p=0.0033)和 miR-122-5p(中位数,P25-P75:5.17[4.81-5.49]vs.5.35[5.01-5.69],p=0.0184)在死亡患者中的表达水平与幸存者不同。miR-21-5p 的 ROC 优化截断值(HR,P25-P75:3.3[1.2-9.4],p=0.0239),但不是 miR-122-5p(HR,P25-P75:0.4[0.2-0.8],p=0.0116),对全因死亡率具有预测性,即使在多变量模型中进行了调整。然而,miR-21-5p 和 miR-122-5p 的添加降低了 hs-cTnT 对全因死亡率的预后准确性(△AUC:0.112,p=0.0159)。hs-cTnT 入院值对 ACM(AUC[95%CI]:0.794[0.751-0.837])和 ACM、AMI 和中风的复合终点(AUC[95%CI]:0.745[0.695-0.794])具有较高的预后价值。
尽管表达水平因结局而异,但 miR-21-5p 和 miR-122-5p 并未为 ED 就诊的疑似 ACS 患者的 hs-cTnT 提供预后信息。